Quantum BioPharma Ltd. is facing a class action lawsuit from shareholder Paul Durkacz, alleging stock manipulation between January 6, 2021, and October 15, 2025. Quantum Biopharma intends to seek appointment as a lead plaintiff in the class action to protect its shareholders. More information can be found on their website. Additionally, Quantum Biopharma has renewed the services of LWM for one month starting December 22, 2025. The company is a biopharmaceutical dedicated to innovative treatments for neurodegenerative and metabolic disorders. They also retain ownership of 19.86% of Unbuzzd Wellness Inc. and have a portfolio of strategic investments.

Read more at GlobeNewswire: World Renowned Law Firm Grant & Eisenhofer Files Class